Tonix Pharmaceuticals (TNXP) Earnings Date, Estimates & Call Transcripts $35.37 +0.20 (+0.57%) As of 02:44 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Tonix Pharmaceuticals Earnings Summary Tonix Pharmaceuticals released Q1 2025 earnings on May 12, 2025, reporting an EPS of -$2.84, which topped the consensus estimate of -$3.23 by $0.39. Quarterly revenue was reported to be $2.43 million, below analysts' expectations of $2.55 million. With a trailing EPS of -$1,963.61, Tonix Pharmaceuticals' earnings are expected to grow next year, from ($1,762.50) to ($541.50) per share. Upcoming Q2 Earnings DateAug. 15Before Market OpensEstimatedConsensus EPS (May. 12) -$3.23 Actual EPS (May. 12) -$2.84 Beat By $0.39 Actual Revenue (May. 12) $2.43MQ1 2025 Earnings ResourcesQ1 2025 Earnings Report Quarterly Report (10-Q) Press Release (8-K)TNXP Upcoming EarningsTonix Pharmaceuticals' next earnings date is estimated for Friday, August 15, 2025, based on past reporting schedules. Powered by Get Tonix Pharmaceuticals Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Tonix Pharmaceuticals and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataTNXP Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.TNXP Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Tonix Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$3.37-$3.37-$3.37Q2 20251-$10.73-$10.73-$10.73Q3 20251-$3.65-$3.65-$3.65Q4 20251-$4.40-$4.40-$4.40 Tonix Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/15/2025(Estimated)--------5/12/2025Q1 2025-$3.23-$2.84+$0.39-$2.84$2.55M$2.43M3/18/2025Q4 2024-$6.23-$9.77 -$3.54-$9.77$3.20M$2.58M11/12/2024--$203.00-$23.00+$180.00-$0.23$2.63M$2.82M8/16/2024--$991.00-$1,928.00 -$937.00-$19.28$3.50M$2.21M5/13/2024Q1 2024-$1,664.00-$576.00+$1,088.00-$0.18$4.00M$2.48M4/1/2024Q4 2023--$2,752.00 -$2,752.00-$0.86$3.95M$3.78M11/9/2023Q3 2023-$4,768.00-$5,856.00 -$1,088.00-$1.83$5.80M$3.99M8/10/2023Q2 2023-$8,896.00-$8,576.00+$320.00-$2.68-- Tonix Pharmaceuticals Earnings - Frequently Asked Questions When is Tonix Pharmaceuticals' earnings date? Tonix Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, August 15th, 2025 based off last year's report dates. Learn more on TNXP's earnings history. Did Tonix Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Tonix Pharmaceuticals (NASDAQ:TNXP) reported ($2.84) earnings per share (EPS) to beat the analysts' consensus estimate of ($3.23) by $0.39. Learn more on analysts' earnings estimate vs. TNXP's actual earnings. How much revenue does Tonix Pharmaceuticals generate each year? Tonix Pharmaceuticals (NASDAQ:TNXP) has a recorded annual revenue of $10.09 million. How much profit does Tonix Pharmaceuticals generate each year? Tonix Pharmaceuticals (NASDAQ:TNXP) has a recorded net income of -$130.04 million. TNXP has generated -$1,963.61 earnings per share over the last four quarters. What is Tonix Pharmaceuticals' EPS forecast for next year? Tonix Pharmaceuticals' earnings are expected to grow from ($1,762.50) per share to ($541.50) per share in the next year. More Earnings Resources from MarketBeat Related Companies ABCL Earnings PAHC Earnings WVE Earnings ELVN Earnings VERV Earnings NTLA Earnings AKBA Earnings COLL Earnings ARDX Earnings PHVS Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Smith & Wesson Stock Falls on Earnings Miss, Tariff WoesWhat to Expect From the Q2 Earnings Reporting CycleBroadcom Slides on Solid Earnings, AI Outlook Still StrongFive Below Pops on Strong Earnings, But Rally May StallRed Robin's Comeback: Q1 Earnings Spark Investor HopesOllie’s Q1 Earnings: The Good, the Bad, and What’s NextBroadcom Earnings Preview: AVGO Stock Near Record Highs This page (NASDAQ:TNXP) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersHere's the last trade you should make before heading out for the weekend tomorrow.Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.Timothy Sykes | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredA grave, grave error.Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the ke...Porter & Company | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | SponsoredThe mainstream media is wrong about AI — againThe mainstream media got it wrong … yet again. AI has recently turned the tech world on its head. And th...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tonix Pharmaceuticals Holding Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tonix Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
